Published in Dtsch Arztebl Int on October 01, 2010
Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch Neurol (2012) 1.37
Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis (2011) 1.13
Brain PET in the diagnosis of Alzheimer's disease. Clin Nucl Med (2014) 0.84
Frequency of dementia syndromes with a potentially treatable cause in geriatric in-patients: analysis of a 1-year interval. Eur Arch Psychiatry Clin Neurosci (2015) 0.82
Back propagation artificial neural network for community Alzheimer's disease screening in China. Neural Regen Res (2013) 0.79
The investigation and differential diagnosis of dementias. Dtsch Arztebl Int (2010) 0.78
Using event-related potential P300 as an electrophysiological marker for differential diagnosis and to predict the progression of mild cognitive impairment: a meta-analysis. Neurol Sci (2015) 0.76
Preclinical non-human models to combat dementia. Ann Neurosci (2013) 0.75
Effects of interventions on physical activity in nursing home residents. Eur J Ageing (2015) 0.75
[Diagnostics and multimodal treatment of depression in old age : New developments]. Z Gerontol Geriatr (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol (2006) 9.99
Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging (1995) 6.86
Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71
Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol (2006) 4.77
Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry (2006) 4.74
Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage (2008) 3.74
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res (2008) 3.15
Mild cognitive impairment: an overview. CNS Spectr (2008) 2.65
A 60-year-old woman with mild memory impairment: review of mild cognitive impairment. JAMA (2008) 2.19
Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology (2006) 2.07
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage (2007) 2.03
Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx (2004) 2.02
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology (2008) 1.80
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging (2007) 1.72
Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain (2008) 1.64
Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord (2007) 1.59
The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry (2006) 1.55
Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2007) 1.47
A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol (2005) 1.42
Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. Eur Psychiatry (2008) 1.31
Odor identification and decline in different cognitive domains in old age. Neuroepidemiology (2005) 1.28
Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry (2003) 1.21
Patterns of subjective memory impairment in the elderly: association with memory performance. Psychol Med (2007) 1.16
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. Eur J Neurol (2008) 1.10
High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients. Int Psychogeriatr (2007) 1.09
Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr (2008) 1.08
Microglial activation in Alzheimer's disease. Curr Alzheimer Res (2009) 1.06
The clock drawing test is a poor screen for very mild dementia. Neurology (2002) 1.06
Amyloid imaging in Alzheimer's disease. Neuropsychologia (2008) 0.97
How are memory complaints in functional memory disorder related to measures of affect, metamemory and cognition? J Psychosom Res (2009) 0.91
Neurochemical dementia diagnostics: assays in CSF and blood. Eur Arch Psychiatry Clin Neurosci (2008) 0.84
Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early alzheimer disease in patients of a memory clinic. Dement Geriatr Cogn Disord (2005) 0.82
The minute hand phenomenon in the Clock Test of patients with early Alzheimer disease. J Geriatr Psychiatry Neurol (2009) 0.79
Use of the clock drawing task in the diagnosis of mild and very mild Alzheimer's disease. Int Psychogeriatr (1996) 0.79
Diagnostic accuracy of the clock drawing test: the relevance of "time setting'' in screening for dementia. J Geriatr Psychiatry Neurol (2008) 0.77
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia. J Neurosci (2008) 3.43
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Predicting clinical scores from magnetic resonance scans in Alzheimer's disease. Neuroimage (2010) 2.33
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry (2009) 2.09
Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: exploring the influence of various parameters. Neuroimage (2010) 1.87
Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease. Neuroimage (2007) 1.83
Consensus paper: combining transcranial stimulation with neuroimaging. Brain Stimul (2009) 1.54
BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res (2006) 1.46
Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Neurobiol Dis (2008) 1.39
[Practice example: neurodegenerative disorders: randomised controlled multicentre trial of home-based occupational therapy for patients with dementia]. Z Evid Fortbild Qual Gesundhwes (2013) 1.38
Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol (2007) 1.34
The future of Alzheimer's disease: the next 10 years. Prog Neurobiol (2011) 1.31
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem (2007) 1.28
Combining functional and anatomical connectivity reveals brain networks for auditory language comprehension. Neuroimage (2009) 1.25
[11C]PIB binding in Parkinson's disease dementia. Neuroimage (2007) 1.24
Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia (2005) 1.22
Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. Int J Neuropsychopharmacol (2010) 1.21
Multicenter stability of diffusion tensor imaging measures: a European clinical and physical phantom study. Psychiatry Res (2011) 1.21
Early functional magnetic resonance imaging activations predict language outcome after stroke. Brain (2010) 1.19
Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinflammation (2007) 1.17
Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI data. PLoS One (2013) 1.15
Association of SORL1 gene variants with Alzheimer's disease. Brain Res (2009) 1.14
The NMDA agonist D-cycloserine facilitates fear memory consolidation in humans. Cereb Cortex (2008) 1.13
Dynamic causal modeling: a generative model of slice timing in fMRI. Neuroimage (2006) 1.13
Damage to ventral and dorsal language pathways in acute aphasia. Brain (2013) 1.11
Influence of dopaminergically mediated reward on somatosensory decision-making. PLoS Biol (2009) 1.09
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord (2009) 1.08
Voxel-based morphometry in eating disorders: correlation of psychopathology with grey matter volume. Psychiatry Res (2010) 1.08
Identification of a blood-based biomarker panel for classification of Alzheimer's disease. Int J Neuropsychopharmacol (2011) 1.07
Microglial activation in Alzheimer's disease. Curr Alzheimer Res (2009) 1.06
Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures. Neuroimage (2009) 1.04
Insomnia does not appear to be associated with substantial structural brain changes. Sleep (2013) 1.03
Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses. J Neurosci (2008) 1.03
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis (2012) 1.02
Effects of hardware heterogeneity on the performance of SVM Alzheimer's disease classifier. Neuroimage (2011) 1.02
A comparison of different automated methods for the detection of white matter lesions in MRI data. Neuroimage (2011) 1.02
Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res (2006) 1.01
Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders. Nat Clin Pract Neurol (2007) 1.00
Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. Glia (2008) 1.00
Multivariate models of inter-subject anatomical variability. Neuroimage (2010) 0.99
Regional distribution of the prostaglandin E2 receptor EP1 in the rat brain: accumulation in Purkinje cells of the cerebellum. J Mol Neurosci (2005) 0.99
Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings. J Neurol (2005) 0.99
BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease. PLoS One (2013) 0.98
Multivariate pattern classification of gray matter pathology in multiple sclerosis. Neuroimage (2012) 0.96
Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells. J Neurochem (2005) 0.94
Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia. J Neurol Sci (2002) 0.93
Neural correlates of interference inhibition, action withholding and action cancelation in adult ADHD. Psychiatry Res (2012) 0.93
Anatomical MRI and DTI in the diagnosis of Alzheimer's disease: a European multicenter study. J Alzheimers Dis (2012) 0.93
Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia. Eur Arch Psychiatry Clin Neurosci (2008) 0.92
How are memory complaints in functional memory disorder related to measures of affect, metamemory and cognition? J Psychosom Res (2009) 0.91
Decreased brain-derived neurotrophic factor (BDNF)- and beta-thromboglobulin (beta-TG)- blood levels in Alzheimer's disease. Thromb Haemost (2006) 0.91
Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB. J Neurochem (2006) 0.90
The effect of handedness on the shape of the central sulcus. Neuroimage (2011) 0.90
Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med (2011) 0.89
Voltage-gated potassium channel/LGI1 antibody-associated encephalopathy may cause brief psychotic disorder. J Clin Psychiatry (2011) 0.89
Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism. Proc Natl Acad Sci U S A (2013) 0.89
The Mini-Cog versus the Mini-Mental State Examination and the Clock Drawing Test in daily clinical practice: screening value in a German Memory Clinic. Int Psychogeriatr (2011) 0.88
The Mini-Cog, Clock Drawing Test, and the Mini-Mental State Examination in a German memory clinic: specificity of separation dementia from depression. Int Psychogeriatr (2012) 0.88
Medial prefrontal dysfunction and prolonged amygdala response during instructed fear processing in borderline personality disorder. World J Biol Psychiatry (2012) 0.87
Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients. J Cereb Blood Flow Metab (2010) 0.87
Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients. J Alzheimers Dis (2010) 0.86
Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia. J Neurochem (2003) 0.86
Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease. PLoS One (2013) 0.85
Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia. J Neuroinflammation (2010) 0.85
Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration. Neuroimage (2013) 0.85
Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer's disease. J Alzheimers Dis (2009) 0.85
Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients. J Alzheimers Dis (2013) 0.85
Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study. J Neuroimaging (2014) 0.85
Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography. Psychiatry Res (2005) 0.84
Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: a contribution to a deficient hematopoietic brain support? J Alzheimers Dis (2008) 0.83
On the role of quantitative brain imaging in the differential diagnosis of speech disorders. Psychiatry Clin Neurosci (2002) 0.83
Quantifying change in individual subjects affected by frontotemporal lobar degeneration using automated longitudinal MRI volumetry. Hum Brain Mapp (2011) 0.83
Homosexual women have less grey matter in perirhinal cortex than heterosexual women. PLoS One (2007) 0.83
Reduced precuneus deactivation during object naming in patients with mild cognitive impairment, Alzheimer's disease, and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord (2010) 0.83
Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses. Psychoneuroendocrinology (2009) 0.83
Suicide attempt as the presenting symptom of C9orf72 dementia. Am J Psychiatry (2012) 0.83
Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders. Neuroreport (2003) 0.83
Impact and Therapeutic Potential of PPARs in Alzheimer's Disease. Curr Neuropharmacol (2011) 0.82
[Information needs of physicians, professional carers and family carers for an evidence-based dementia website]. Psychiatr Prax (2011) 0.82
Left anterior temporal lobe sustains naming in Alzheimer's dementia and mild cognitive impairment. Curr Alzheimer Res (2011) 0.82
A multicentre RCT on community occupational therapy in Alzheimer's disease: 10 sessions are not better than one consultation. BMJ Open (2011) 0.82
Study protocol of the multi-site randomised controlled REDALI-DEM trial--the effects of structured relearning methods on daily living task performance of persons with dementia. BMC Geriatr (2011) 0.81
[Daily functioning in dementia: pharmacological and non-pharmacological interventions demonstrate small effects on heterogeneous scales]. Psychiatr Prax (2011) 0.81
Cerebral small vessel disease: how does it progress? J Neurol Sci (2005) 0.81
Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res (2005) 0.81
Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia. J Nucl Med (2013) 0.80
1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH. J Neurochem (2004) 0.80
Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production. J Neuroimmunol (2006) 0.80
Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls. J Alzheimers Dis (2009) 0.80
Interview for Deterioration in Daily Living Activities in Dementia: construct and concurrent validity in patients with mild to moderate dementia. Int Psychogeriatr (2012) 0.80
Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease. J Alzheimers Dis (2008) 0.80
Longitudinal cerebral diffusion changes reflect progressive decline of language and cognition. Psychiatry Res (2013) 0.79
Clock test deficits related to the global cognitive state in Alzheimer's and Parkinson's disease. Dement Geriatr Cogn Disord (2012) 0.79
Prolonged coma caused by low sodium and hypo-osmolarity during treatment with citalopram. J Clin Psychopharmacol (2002) 0.79
Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia. Clin Nucl Med (2015) 0.79
Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease. J Psychiatr Res (2007) 0.79